A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
Status:
RECRUITING
Trial end date:
2027-11-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine recommended phase 2 doses (RP2Ds) of JNJ-95437446 in Part 1, and to further evaluate the safety of the RP2Ds in participants with advanced solid tumors in Part 2.